Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Lung Neoplasms 6Neoplasms 4Colonic Neoplasms 3Prostatic Neoplasms 2Patient Satisfaction 2Ovarian Neoplasms 2Breast Neoplasms 2Brain Neoplasms 2Urinary Bladder Neoplasms 1Tuberculosis, Pulmonary 1Thoracic Diseases 1Supratentorial Neoplasms 1Stomach Ulcer 1Stomach Neoplasms 1Recurrence 1Rectal Neoplasms 1Polyps 1Pituitary Neoplasms 1Pain, Postoperative 1Pain 1Overweight 1Obesity 1Neurofibromatoses 1Neoplastic Cells, Circulating 1Neoplasm Metastasis 1Mouth Neoplasms 1Melanoma 1Liver Neoplasms 1Kidney Neoplasms 1Hypoxia 1

Interventions

Propofol 1Alfentanil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Tuberculosis, Pulmonary × Propofol × Clear all
NCT07395596 2026-02-24

Remimazolam for Bronchoscopy in High-Risk Patients

First Affiliated Hospital of Zhejiang University

Phase 4 Recruiting
360 enrolled

Hypoxia, Tuberculosis, Pulmonary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡